Kronos Bio, Inc.
KRON · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $50 | $57 | $60 | $67 |
| - Cash | $92 | $85 | $75 | $70 |
| + Debt | $24 | $25 | $26 | $27 |
| Enterprise Value | -$17 | -$2 | $11 | $24 |
| Revenue | $2 | $2 | $2 | $3 |
| % Growth | -17.9% | -4.2% | -11.8% | – |
| Gross Profit | $2 | $2 | $2 | $3 |
| % Margin | 81.3% | 100% | 100% | 100% |
| EBITDA | -$6 | -$11 | -$15 | -$17 |
| % Margin | -330.2% | -469.3% | -645.7% | -633.4% |
| Net Income | -$8 | -$26 | -$14 | -$16 |
| % Margin | -448.7% | -1,137.1% | -595.3% | -602.7% |
| EPS Diluted | -0.14 | -0.43 | -0.23 | -0.27 |
| % Growth | 67.4% | -87% | 14.8% | – |
| Operating Cash Flow | -$13 | -$13 | -$12 | -$16 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$13 | -$13 | -$12 | -$16 |